Namita S. Dodwadkar

Liposomes loaded with paclitaxel and modified with novel triphenylphosphonium-PEG-PE conjugate possess low toxicity, target mitochondria and demonstrate enhanced antitumor effects in vitro and in vivo

Swati Biswas, Namita S. Dodwadkar, Pranali P. Deshpande et al. · Journal of Controlled Release · 2012 · 274 citations

Pharmacy, Oncology, Pharmacology +14

Lipid modified triblock PAMAM-based nanocarriers for siRNA drug co-delivery

Swati Biswas, Pranali P. Deshpande, Gemma Navarro et al. · Biomaterials · 2012 · 197 citations · Full text

Pharmacy, Molecular Pharmaceutics, Pharmaceutics +14

Surface conjugation of triphenylphosphonium to target poly(amidoamine) dendrimers to mitochondria

Swati Biswas, Namita S. Dodwadkar, Aleksandr Piroyan et al. · Biomaterials · 2012 · 171 citations

Pharmacy, Chemistry, Medicinal Chemistry +7

Octa-arginine-modified pegylated liposomal doxorubicin: An effective treatment strategy for non-small cell lung cancer

Swati Biswas, Pranali P. Deshpande, Federico Perche et al. · Cancer Letters · 2013 · 88 citations · Full text

Pharmacy, Oncology, Pharmacology +16

Surface modification of liposomes with rhodamine-123-conjugated polymer results in enhanced mitochondrial targeting

Swati Biswas, Namita S. Dodwadkar, Rupa R. Sawant et al. · Journal of drug targeting · 2011 · 86 citations · Full text

Pharmacy, Pharmaceutics, Pharmacology +17